Evidence map›Paper›PMID 33912188›Full record

ArticleFrontiers in immunology2021

Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands.

Shuvasree SenGupta, Lauren E Hein, Yang Xu, Jason Zhang, Jamie R Konwerski, Ye Li, Craig Johnson, Dawen Cai, Janet L Smith, Carole A Parent

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Subtype-Independent Activation of NF-κB Signaling in Breast Cancer.International journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. 3D bioprinting innovations: a new frontier in breast cancer research.Medical oncology (Northwood, London, England) · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shuvasree SenGuptaDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, United States.
Lauren E HeinCancer Biology Graduate Program, University of Michigan Medical School, Ann Arbor, MI, United States.
Yang XuDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, United States.
Jason ZhangDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, United States.
Jamie R KonwerskiDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, United States.
Ye LiDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, United States.
Craig JohnsonDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, United States.
Dawen CaiDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, United States.
Janet L SmithDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, United States.
Carole A ParentDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, United States.
University of Michigan–Ann Arbor · US

Funding

STRUCTURE AND FUNCTION OF A PURINE BIOSYNTHETIC ENZYMER01DK042303 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, JANET L. · 1990 to 2024
$6.6M
NIDDK NIH HHS R01 DK042303
6 · The paper itself

Abstract

Tumor associated neutrophils (TANs) are frequently detected in triple-negative breast cancer (TNBC). Recent studies also reveal the importance of neutrophils in promoting tumor progression and metastasis during breast cancer. However, the mechanisms regulating neutrophil trafficking to breast tumors are less clear. We sought to determine whether neutrophil trafficking to breast tumors is determined directly by the malignant potential of cancer cells. We found that tumor conditioned media (TCM) harvested from highly aggressive, metastatic TNBC cells induced a polarized morphology and robust neutrophil migration, while TCM derived from poorly aggressive estrogen receptor positive (ER+) breast cancer cells had no activity. In a three-dimensional (3D) type-I collagen matrix, neutrophils migrated toward TCM from aggressive breast cancer cells with increased velocity and directionality. Moreover, in a neutrophil-tumor spheroid co-culture system, neutrophils migrated with increased directionality towards spheroids generated from TNBC cells compared to ER+ cells. Based on these findings, we next sought to characterize the active factors secreted by TNBC cell lines. We found that TCM-induced neutrophil migration is dependent on tumor-derived chemokines, and screening TCM elution fractions based on their ability to induce polarized neutrophil morphology revealed the molecular weight of the active factors to be around 12 kDa. TCM from TNBC cell lines contained copious amounts of GRO (CXCL1/2/3) chemokines and TGF-β cytokines compared to ER+ cell-derived TCM. TCM activity was inhibited by simultaneously blocking receptors specific to GRO chemokines and TGF-β, while the activity remained intact in the presence of either single receptor inhibitor. Together, our findings establish a direct link between the malignant potential of breast cancer cells and their ability to induce neutrophil migration. Our study also uncovers a novel coordinated function of TGF-β and GRO chemokines responsible for guiding neutrophil trafficking to the breast tumor.

Indexed as

Cell LineCell Line, TumorCell MovementCells, CulturedChemokinesCulture Media, ConditionedCytokinesFemaleHumansLigandsMCF-7 CellsNeutrophil InfiltrationNeutrophilsReceptors, Interleukin-8BTransforming Growth Factor betaTriple Negative Breast NeoplasmsChemokinesCulture Media, ConditionedCXCR2 protein, humanCytokinesLigandsReceptors, Interleukin-8BTransforming Growth Factor betabreast cancerchemotaxisCXCL1/2/3neutrophilTGF-βTNBCtumor spheroid

Identifiers

PMID33912188
PMCPMC8071875
OpenAlexW3153481985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.